Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal corticosteroids combined with inhaled budesonide/formoterol for simple asthma
ChiCTR-TRC-12003516Phase 4Completed
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of budesonide and formoterol in asthma (2 arms), sponsored by Guangzhou Institute of Respiratory Health. Primary endpoints: Eosinophils in nasal lavage, Eosinophils in induced sputum and 6 more. Started Aug 2012; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-12003516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003516.